A medical tests company is setting up a research and development centre in Londonderry where it will develop a test to identify osteoporosis risk.
Crescent Diagnostics is based at University College, Dublin but also has a lab at the Clinical Translation Research and Innovation Centre in Derry. The project has received £23,000 in assistance from Invest Northern Ireland and is likely to take six months to complete.
Invest NI chief executive Alastair Hamilton said the company aimed to create a breakthrough test identifying people at high risk of a hip fracture, "the most devastating consequence of osteoporosis".
"Osteoporosis has become a major public health issue and Crescent has identified a market need for an improved diagnostic tool.
"By carrying out the research and development project in Londonderry, Crescent is planning to tap into the research capability at Queen's University as well as the extensive facilities at C-TRIC.
Crescent chief executive Brendan Farrell said: "Our technology will help clinicians identify at-risk patients early, revolutionising the diagnosis of the disease."